Verdezyne Sells One of Its Technologies to DuPont Industrial Biosciences

Posted on: December 18, 2012 by Connie LoizosNo Comments »

Verdezyne, an industrial biotechnology company based in Carlsbad, Calif., has sold its proprietary xylose isomerase technology to DuPont Industrial Biosciences for an undisclosed amount. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners and Monitor Ventures.